Sign inGet started

Hassan Fred

Insider CIK 1110744 · TWX Director · EYPT Director · XON Director · COCP Director · RXDX Director · BBIO Director · AMGN Director · VRX Director · AVP Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BBIO BridgeBio Pharma, Inc. A Award deriv2026-06-222026-06-245,277— $05,277SEC↗
BBIO BridgeBio Pharma, Inc. A Award2026-06-222026-06-243,990— $029,879SEC↗
PGEN PRECIGEN, INC. M Exercise deriv2026-03-132026-03-1671,839— $00SEC↗
PGEN PRECIGEN, INC. M Exercise2026-03-132026-03-1671,839— $01,243,239SEC↗
PGEN PRECIGEN, INC. A Award deriv2026-03-102026-03-1235,612— $035,612SEC↗
PGEN PRECIGEN, INC. A Award deriv2026-03-102026-03-1241,073— $041,073SEC↗
PGEN PRECIGEN, INC. A Award2026-03-102026-03-1217,948$3.51 $63.0K1,171,400SEC↗
COCP Cocrystal Pharma, Inc. A Award deriv2026-01-092026-01-1316,410— $016,410SEC↗
EYPT EyePoint, Inc. A Award deriv2026-01-022026-01-0640,000— $040,000SEC↗
COCP Cocrystal Pharma, Inc. A Award deriv2025-10-282025-10-30719,426$1.39 $1.00M719,426SEC↗
COCP Cocrystal Pharma, Inc. A Award2025-10-282025-10-30359,713$1.39 $500.0K1,383,009SEC↗
BBIO BridgeBio Pharma, Inc. A Award deriv2025-06-202025-06-248,425— $08,425SEC↗
BBIO BridgeBio Pharma, Inc. A Award2025-06-202025-06-246,589— $025,889SEC↗
PGEN PRECIGEN, INC. M Exercise deriv2025-03-142025-03-1787,412— $00SEC↗
PGEN PRECIGEN, INC. M Exercise2025-03-142025-03-1787,412— $01,153,452SEC↗
PGEN PRECIGEN, INC. A Award deriv2025-03-132025-03-1771,839— $071,839SEC↗
PGEN PRECIGEN, INC. A Award deriv2025-03-132025-03-1783,517— $083,517SEC↗
PGEN PRECIGEN, INC. A Award2025-03-132025-03-1736,206$1.74 $63.0K1,066,040SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2025-01-032025-01-0740,000— $040,000SEC↗
COCP Cocrystal Pharma, Inc. A Award2024-10-092024-10-118,067— $01,023,296SEC↗
EYPT EyePoint Pharmaceuticals, A Award deriv2024-09-032024-09-0560,000— $060,000SEC↗
BBIO BridgeBio Pharma, Inc. A Award deriv2024-06-212024-06-2526,014— $026,014SEC↗
PGEN PRECIGEN, INC. A Award deriv2024-03-142024-03-1887,412— $087,412SEC↗
PGEN PRECIGEN, INC. A Award deriv2024-03-142024-03-18101,626— $0101,626SEC↗
PGEN PRECIGEN, INC. A Award2024-03-142024-03-1844,055$1.43 $63.0K1,029,834SEC↗
PGEN PRECIGEN, INC. M Exercise deriv2024-03-092024-03-12106,837— $00SEC↗
PGEN PRECIGEN, INC. M Exercise2024-03-092024-03-12106,837— $0985,779SEC↗
PGEN PRECIGEN, INC. P Buy2023-08-142023-08-16570,345$1.75 $998.1K878,942SEC↗
COCP Cocrystal Pharma, Inc. A Award deriv2023-07-182023-07-207,333— $07,333SEC↗
BBIO BridgeBio Pharma, Inc. A Award deriv2023-06-212023-06-2351,501— $051,501SEC↗
RXDX Prometheus Biosciences, In D To issuer deriv2023-06-162023-06-16541— $00SEC↗
RXDX Prometheus Biosciences, In D To issuer deriv2023-06-162023-06-1640,000— $00SEC↗
RXDX Prometheus Biosciences, In D To issuer deriv2023-06-162023-06-1621,013— $00SEC↗
RXDX Prometheus Biosciences, In D To issuer2023-06-162023-06-162,123— $00SEC↗
RXDX Prometheus Biosciences, In A Award2023-05-192023-05-192,123— $02,123SEC↗
PGEN PRECIGEN, INC. A Award deriv2023-03-092023-03-13106,837— $0106,837SEC↗
PGEN PRECIGEN, INC. A Award deriv2023-03-092023-03-13125,489— $0125,489SEC↗
PGEN PRECIGEN, INC. A Award2023-03-092023-03-1348,290$1.17 $56.5K308,597SEC↗
PGEN PRECIGEN, INC. M Exercise deriv2023-02-222023-02-2461,576— $00SEC↗
PGEN PRECIGEN, INC. M Exercise2023-02-222023-02-2461,576— $0260,307SEC↗
BBIO BridgeBio Pharma, Inc. A Award deriv2022-06-222022-06-24104,921— $0104,921SEC↗
RXDX Prometheus Biosciences, In A Award deriv2022-05-192022-05-2021,013— $021,013SEC↗
PGEN PRECIGEN, INC. M Exercise deriv2022-03-252022-03-2916,212— $00SEC↗
PGEN PRECIGEN, INC. M Exercise2022-03-252022-03-2916,212— $0198,731SEC↗
PGEN PRECIGEN, INC. A Award deriv2022-02-222022-02-2461,576— $061,576SEC↗
PGEN PRECIGEN, INC. A Award deriv2022-02-222022-02-2483,189— $083,189SEC↗
PGEN PRECIGEN, INC. A Award2022-02-222022-02-2427,832$2.03 $56.5K182,519SEC↗
BBIO BridgeBio Pharma, Inc. P Buy2021-12-292022-01-0319,300$14.17 $273.5K19,300SEC↗
RXDX Prometheus Biosciences, In A Award deriv2021-11-142021-11-16541— $0541SEC↗
BBIO BridgeBio Pharma, Inc. A Award deriv2021-08-172021-08-2649,869— $049,869SEC↗
RXDX Prometheus Biosciences, In A Award deriv2021-05-142021-05-1740,000— $040,000SEC↗
PGEN PRECIGEN, INC. A Award deriv2021-03-252021-03-2916,212— $016,212SEC↗
PGEN PRECIGEN, INC. A Award deriv2021-03-252021-03-2922,107— $022,107SEC↗
PGEN PRECIGEN, INC. A Award2021-03-252021-03-297,328$7.71 $56.5K154,687SEC↗
PGEN PRECIGEN, INC. M Exercise deriv2021-03-132021-03-1662,189— $00SEC↗
PGEN PRECIGEN, INC. M Exercise2021-03-132021-03-1662,189— $0147,359SEC↗
AMGN AMGEN INC A Award2020-05-052020-05-07846— $09,191SEC↗
PGEN PRECIGEN, INC. A Award deriv2020-03-132020-03-1796,324— $096,324SEC↗
PGEN PRECIGEN, INC. A Award deriv2020-03-132020-03-1762,189— $062,189SEC↗
PGEN PRECIGEN, INC. A Award2020-03-132020-03-1728,109$2.01 $56.5K85,170SEC↗
PGEN PRECIGEN, INC. M Exercise deriv2020-03-082020-03-1024,703— $00SEC↗
PGEN PRECIGEN, INC. M Exercise2020-03-082020-03-1024,703— $057,061SEC↗
AMGN AMGEN INC A Award2019-05-032019-05-071,127— $08,345SEC↗
XON INTREXON CORP M Exercise deriv2019-03-232019-03-267,911— $00SEC↗
XON INTREXON CORP M Exercise2019-03-232019-03-267,911— $032,358SEC↗
XON INTREXON CORP A Award deriv2019-03-082019-03-1824,703— $032,614SEC↗
XON INTREXON CORP A Award deriv2019-03-082019-03-1842,450— $042,450SEC↗
XON INTREXON CORP A Award2019-03-082019-03-1811,166$5.06 $56.5K24,447SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-185,336— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-182,996— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-182,898— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-184,880— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-183,108— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-185,708— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-184,019— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-181,128— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer deriv2018-06-142018-06-182,460— $00SEC↗
TWX WARNER MEDIA, LLC D To issuer2018-06-142018-06-1849,089— $00SEC↗
TWX TIME WARNER INC. M Exercise deriv2018-06-012018-06-042,117— $00SEC↗
TWX TIME WARNER INC. M Exercise2018-06-012018-06-042,117— $049,089SEC↗
TWX TIME WARNER INC. A Award deriv2018-05-012018-05-025$94.36 $4521,128SEC↗
AMGN AMGEN INC A Award2018-04-272018-05-011,127— $07,218SEC↗
XON INTREXON CORP A Award deriv2018-03-232018-03-2914,246— $014,246SEC↗
XON INTREXON CORP A Award deriv2018-03-232018-03-297,911— $07,911SEC↗
XON INTREXON CORP A Award2018-03-232018-03-293,575$15.80 $56.5K13,281SEC↗
TWX TIME WARNER INC. A Award deriv2018-02-012018-02-025$96.90 $4511,124SEC↗
TWX TIME WARNER INC. A Award deriv2017-11-012017-11-025$98.45 $4491,119SEC↗
TWX TIME WARNER INC. A Award deriv2017-08-012017-08-024$102.64 $4461,114SEC↗
TWX TIME WARNER INC. A Award deriv2017-06-162017-06-202,117— $02,117SEC↗
TWX TIME WARNER INC. A Award deriv2017-06-152017-06-191,110— $01,110SEC↗
TWX TIME WARNER INC. M Exercise deriv2017-06-012017-06-021,382— $00SEC↗
TWX TIME WARNER INC. M Exercise2017-06-012017-06-021,382— $046,972SEC↗
AMGN AMGEN INC A Award2017-05-012017-05-031,230— $06,091SEC↗
XON INTREXON CORP A Award deriv2017-03-162017-03-2015,000— $015,000SEC↗
XON INTREXON CORP A Award2017-03-162017-03-202,806— $09,706SEC↗
XON INTREXON CORP P Buy2016-12-012016-12-056,900$29.02 $200.2K6,900SEC↗
XON INTREXON CORP A Award deriv2016-06-302016-07-1315,000— $015,000SEC↗
XON INTREXON CORP A Award deriv2016-06-302016-07-1340,000— $040,000SEC↗
TWX TIME WARNER INC. A Award deriv2016-06-182016-06-213,108— $03,108SEC↗
TWX TIME WARNER INC. A Award deriv2016-06-182016-06-211,382— $01,382SEC↗
TWX TIME WARNER INC. M Exercise deriv2016-06-012016-06-021,136— $00SEC↗
TWX TIME WARNER INC. M Exercise2016-06-012016-06-021,136— $045,590SEC↗
AMGN AMGEN INC A Award2016-05-032016-05-051,279— $04,861SEC↗
AMGN AMGEN INC P Buy2015-08-192015-08-203,000$166.64 $499.9K3,572SEC↗
AMGN AMGEN INC P Buy2015-08-192015-08-2010$165.50 $1.7K3,582SEC↗
AMGN AMGEN INC A Award2015-08-042015-08-06572— $0572SEC↗
TWX TIME WARNER INC. A Award deriv2015-06-202015-06-232,460— $02,460SEC↗
TWX TIME WARNER INC. A Award deriv2015-06-202015-06-231,136— $01,136SEC↗
TWX TIME WARNER INC. M Exercise deriv2015-06-012015-06-021,474— $00SEC↗
TWX TIME WARNER INC. M Exercise2015-06-012015-06-021,474— $044,454SEC↗
TWX TIME WARNER INC. A Award deriv2014-06-142014-06-171,474— $01,474SEC↗
TWX TIME WARNER INC. A Award deriv2014-06-142014-06-172,898— $02,898SEC↗
TWX TIME WARNER INC. M Exercise deriv2014-05-012014-05-021,434— $00SEC↗
TWX TIME WARNER INC. M Exercise2014-05-012014-05-021,434— $042,980SEC↗
VRX Valeant Pharmaceuticals In P Buy2013-08-292013-09-0351,000$99.01 $5.05M53,969SEC↗
VRX Valeant Pharmaceuticals In A Award2013-08-222013-08-232,969— $02,969SEC↗
TWX TIME WARNER INC. A Award deriv2013-05-242013-05-281,434— $01,434SEC↗
TWX TIME WARNER INC. A Award deriv2013-05-242013-05-282,872— $02,872SEC↗
TWX TIME WARNER INC. M Exercise deriv2013-05-012013-05-022,410— $00SEC↗
TWX TIME WARNER INC. M Exercise2013-05-012013-05-022,410— $041,546SEC↗
TWX TIME WARNER INC. A Award deriv2012-05-162012-05-182,410— $02,410SEC↗
TWX TIME WARNER INC. A Award deriv2012-05-162012-05-185,115— $05,115SEC↗
AVP AVON PRODUCTS INC A Award deriv2012-05-032012-05-075,476— $05,476SEC↗
TWX TIME WARNER INC. M Exercise deriv2012-05-012012-05-022,310— $00SEC↗
TWX TIME WARNER INC. M Exercise2012-05-012012-05-022,310— $039,136SEC↗